Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Weiner

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
American Journal of Physiology. Renal Physiology|December 7, 2023
Angiotensin II acts through Rac1 to upregulate pendrin: role of NADPH oxidaseTruyen D Pham, Jill W Verlander, Chao Chen, et al.
Nephron. Experimental Nephrology|September 9, 2008
Expression of ammonia transporters, Rhbg and Rhcg, in chronic cyclosporine nephropathy in ratsSun Woo Lim, Kyung Ohk Ahn, Wan Young Kim, et al.
Journal of Medicinal Chemistry|November 1, 2002
Discovery of the first nonpeptide agonist of the GPR14/urotensin-II receptor: 3-(4-chlorophenyl)-3-(2- (dimethylamino)ethyl)isochroman-1-one (AC-7954)Glenn E Croston, Roger Olsson, Erika A Currier, et al.
The Journal of Endocrinology|March 11, 2021
Regulation of Rhcg, an ammonia transporter, by aldosterone in the kidneyKoji Eguchi, Yuichiro Izumi, Yukiko Yasuoka, et al.
American Journal of Physiology. Renal Physiology|September 17, 2011
Angiotensin II acts through the angiotensin 1a receptor to upregulate pendrinJill W Verlander, Seongun Hong, Vladimir Pech, et al.
The Journal of Biological Chemistry|March 16, 2019
Ethanol sensitizes skeletal muscle to ammonia-induced molecular perturbationsSashi Kant, Gangarao Davuluri, Khaled A Alchirazi, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 7, 2025
Evaluating the demographics and complications of North American surgical patients with ossification of the posterior longitudinal ligamentAaron Phung, Justin Hyde, Justin Azmoodeh, et al.
Nature Communications|December 16, 2017
Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancerFilippo Veglia, Vladimir A Tyurin, Dariush Mohammadyani, et al.
Journal for Immunotherapy of Cancer|July 7, 2021
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumorsRobert H Vonderheide, Kimberly A Kraynyak, Anthony F Shields, et al.
JAMA Neurology|December 14, 2020
Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical TrialTanya Simuni, Brian Fiske, Kalpana Merchant, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
American Journal of Physiology. Renal Physiology|December 7, 2023
Angiotensin II acts through Rac1 to upregulate pendrin: role of NADPH oxidaseTruyen D Pham, Jill W Verlander, Chao Chen, et al.
Nephron. Experimental Nephrology|September 9, 2008
Expression of ammonia transporters, Rhbg and Rhcg, in chronic cyclosporine nephropathy in ratsSun Woo Lim, Kyung Ohk Ahn, Wan Young Kim, et al.
Journal of Medicinal Chemistry|November 1, 2002
Discovery of the first nonpeptide agonist of the GPR14/urotensin-II receptor: 3-(4-chlorophenyl)-3-(2- (dimethylamino)ethyl)isochroman-1-one (AC-7954)Glenn E Croston, Roger Olsson, Erika A Currier, et al.
The Journal of Endocrinology|March 11, 2021
Regulation of Rhcg, an ammonia transporter, by aldosterone in the kidneyKoji Eguchi, Yuichiro Izumi, Yukiko Yasuoka, et al.
American Journal of Physiology. Renal Physiology|September 17, 2011
Angiotensin II acts through the angiotensin 1a receptor to upregulate pendrinJill W Verlander, Seongun Hong, Vladimir Pech, et al.
The Journal of Biological Chemistry|March 16, 2019
Ethanol sensitizes skeletal muscle to ammonia-induced molecular perturbationsSashi Kant, Gangarao Davuluri, Khaled A Alchirazi, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 7, 2025
Evaluating the demographics and complications of North American surgical patients with ossification of the posterior longitudinal ligamentAaron Phung, Justin Hyde, Justin Azmoodeh, et al.
Nature Communications|December 16, 2017
Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancerFilippo Veglia, Vladimir A Tyurin, Dariush Mohammadyani, et al.
Journal for Immunotherapy of Cancer|July 7, 2021
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumorsRobert H Vonderheide, Kimberly A Kraynyak, Anthony F Shields, et al.
JAMA Neurology|December 14, 2020
Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical TrialTanya Simuni, Brian Fiske, Kalpana Merchant, et al.
Pageof 12